Asarina Pharma

Developer of drugs for the premenstrual dysphoric disorder (PMDD)

placeUmea, Vasterbotten County, Sweden calendar_todayFounded 2006 groups5 employees language asarinapharma.com

Registered entities

Investor mix

9 investors on record; lead investors include Idinvest Partners, Ergomed.

Investor typeCountShare
Venture capital444%
Private equity111%
Other / undisclosed444%
Coming soon